Follow Us TR

News Details

TRACON Pharmaceuticals Announces FDA Clearance of ENVASARC Pivotal Trial

About TRACON Pharmaceuticals, Inc.
  • NASDAQ: $TCON
  • Notified: $2.46
  • 08:05 EDT

Price Chart